Lingying Ma

439 total citations
25 papers, 268 citations indexed

About

Lingying Ma is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Nephrology. According to data from OpenAlex, Lingying Ma has authored 25 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 9 papers in Epidemiology and 7 papers in Nephrology. Recurrent topics in Lingying Ma's work include Vasculitis and related conditions (18 papers), Renal Diseases and Glomerulopathies (6 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Lingying Ma is often cited by papers focused on Vasculitis and related conditions (18 papers), Renal Diseases and Glomerulopathies (6 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Lingying Ma collaborates with scholars based in China, Spain and United States. Lingying Ma's co-authors include Huiyong Chen, Ying Sun, Lili Ma, Xiaomin Dai, Lindi Jiang, Zongfei Ji, Xiaomeng Cui, Lindi Jiang, Xiufang Kong and Rongyi Chen and has published in prestigious journals such as Annals of Oncology, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Lingying Ma

24 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingying Ma China 11 165 107 73 68 67 25 268
Jan Henrik Schirmer Germany 9 210 1.3× 97 0.9× 36 0.5× 40 0.6× 33 0.5× 22 293
Diana Castillo‐Martínez Mexico 11 54 0.3× 125 1.2× 63 0.9× 30 0.4× 74 1.1× 17 245
Sibel Z. Aydin Türkiye 10 318 1.9× 208 1.9× 67 0.9× 29 0.4× 89 1.3× 11 386
Pierre‐Antoine Juge France 8 77 0.5× 110 1.0× 16 0.2× 49 0.7× 77 1.1× 32 217
Justyna Fijołek Poland 11 163 1.0× 89 0.8× 23 0.3× 52 0.8× 20 0.3× 34 246
Chiara Marvisi Italy 12 192 1.2× 279 2.6× 31 0.4× 93 1.4× 22 0.3× 41 374
Ana Águeda Portugal 6 149 0.9× 126 1.2× 40 0.5× 13 0.2× 42 0.6× 18 216
Mitsuharu Mori Japan 6 59 0.4× 30 0.3× 41 0.6× 78 1.1× 26 0.4× 25 201
Cengiz Canpolat Türkiye 10 60 0.4× 36 0.3× 40 0.5× 33 0.5× 19 0.3× 29 223
Vincent Grobost France 10 91 0.6× 71 0.7× 29 0.4× 56 0.8× 13 0.2× 20 245

Countries citing papers authored by Lingying Ma

Since Specialization
Citations

This map shows the geographic impact of Lingying Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingying Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingying Ma more than expected).

Fields of papers citing papers by Lingying Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingying Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingying Ma. The network helps show where Lingying Ma may publish in the future.

Co-authorship network of co-authors of Lingying Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Lingying Ma. A scholar is included among the top collaborators of Lingying Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingying Ma. Lingying Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Sifan, Bing Wu, Lingying Ma, et al.. (2025). Association of PET vascular activity score with Takayasu’s arteritis angiographic progression. European Journal of Nuclear Medicine and Molecular Imaging. 52(11). 4268–4280. 1 indexed citations
2.
Chen, Rongyi, Lingying Ma, Xiaomin Dai, et al.. (2023). High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study. Arthritis Research & Therapy. 25(1). 137–137. 2 indexed citations
3.
4.
Kong, Xiufang, Sifan Wu, Ying Sun, et al.. (2022). A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis. Arthritis Research & Therapy. 24(1). 49–49. 10 indexed citations
5.
Chen, Lingli, Ying Sun, Lingying Ma, et al.. (2022). Clinical and pathological predictors of relapse in IgG4-related disease. Arthritis Research & Therapy. 24(1). 106–106. 15 indexed citations
6.
7.
Ma, Lingying, Sifan Wu, Xuejuan Jin, et al.. (2022). Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study. Seminars in Arthritis and Rheumatism. 55. 152018–152018. 19 indexed citations
8.
Wang, Yujiao, Lili Ma, Yun Liu, et al.. (2021). Risk assessment model for heart failure in Chinese patients with Takayasu’s arteritis. Clinical Rheumatology. 40(10). 4117–4126. 3 indexed citations
9.
Chen, Rongyi, Lingying Ma, Peng Lv, et al.. (2021). Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis. Arthritis Research & Therapy. 23(1). 63–63. 15 indexed citations
10.
Kong, Xiufang, Ming Xu, Xiaomeng Cui, et al.. (2021). Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis. Frontiers in Immunology. 12. 646516–646516. 16 indexed citations
11.
Ma, Lingying, Bing Wu, Xuejuan Jin, et al.. (2021). A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study. Lara D. Veeken. 61(SI). SI14–SI22. 14 indexed citations
12.
Chen, Rongyi, Xiaomeng Cui, Lili Ma, et al.. (2020). In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease. Frontiers in Immunology. 11. 1272–1272. 24 indexed citations
13.
Ma, Lingying, Lijuan Zhang, Ying Sun, et al.. (2020). Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study. Clinical Rheumatology. 40(6). 2293–2300. 16 indexed citations
14.
Sun, Ying, Xiaomin Dai, Peng Lv, et al.. (2020). Characteristics and Medium-term Outcomes of Takayasu Arteritis–related Renal Artery Stenosis: Analysis of a Large Chinese Cohort. The Journal of Rheumatology. 48(1). 87–93. 9 indexed citations
15.
Ma, Lingying, et al.. (2020). AB0491 ELEVATED COMPLEMENT 3 INDICATES DISEASE ACTIVITY IN TAKAYASU ARTERITIS. Annals of the Rheumatic Diseases. 79. 1543–1543. 1 indexed citations
16.
Ma, Lingying, Chaolun Li, Xiaomeng Cui, et al.. (2019). Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis. Arthritis Research & Therapy. 21(1). 24–24. 35 indexed citations
17.
Ma, Lili, Xiaomin Dai, Yujiao Wang, et al.. (2019). Serum leptin, a potential predictor of long‐term angiographic progression in Takayasu’s arteritis. International Journal of Rheumatic Diseases. 22(12). 2134–2142. 5 indexed citations
18.
Sun, Ying, Lili Ma, Lingying Ma, et al.. (2017). Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu’s arteritis. Rheumatology International. 37(12). 2019–2026. 28 indexed citations
19.
Wang, Zheng, et al.. (2015). 218P Protein tyrosine phosphatase PTPN3 inhibits hepatocellular carcinoma growth and metastasis by dephosphorylation of EGFR. Annals of Oncology. 26. ix42–ix42. 1 indexed citations
20.
Lei, Wei, Lili Ma, Huiyong Chen, et al.. (2015). Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease. Clinical Rheumatology. 34(9). 1605–1611. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Henrik Schirmer Breakdown of academic impact, for papers by Diana Castillo‐Martínez Breakdown of academic impact, for papers by Sibel Z. Aydin Breakdown of academic impact, for papers by Pierre‐Antoine Juge Breakdown of academic impact, for papers by Justyna Fijołek Breakdown of academic impact, for papers by Chiara Marvisi Breakdown of academic impact, for papers by Ana Águeda Breakdown of academic impact, for papers by Mitsuharu Mori Breakdown of academic impact, for papers by Cengiz Canpolat Breakdown of academic impact, for papers by Vincent Grobost
Rankless by CCL
2026